CD8A and neoplasm: In vivo, OXP+FG presented remarkable enhanced anti-tumor effect in both subcutaneous model and abdominal metastasis model in comparison with NS, FG and OXP alone, through increasing activated CD8+ T cells, reducing Treg cells and evoking more IFN-γ.